TickerFacts.

Cryoport, Inc. (CYRX): Share Repurchases

Annual figures by period end, from SEC filings.

$10.01M
Year ended 2025-12-31
-35.9%
3-year compound annual growth
$37.96M2020-12-31: $02021-12-31: $02022-12-31: $37.96M2025-12-31: $10.01M$10.01M
2020-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$10.01Mn/a2026-03-05, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31$37.96Mn/a2025-03-07, From 2022-01-01
2021-12-31$0n/a2023-02-28, From 2021-01-01
2020-12-31$0n/a2023-02-28, From 2020-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%
Anaptysbio, Inc (ANAB)2025-12-31$68.63Mn/m
Keros Therapeutics, Inc. (KROS)2025-12-31$375.00Mn/a
Arvinas, Inc. (ARVN)2025-12-31$91.90Mn/a
Ligand Pharmaceuticals Inc (LGND)2025-12-31$15.00Mn/a
Theravance Biopharma, Inc. (TBPH)2024-12-31$445.0K-99.8%
Zevra Therapeutics, Inc. (ZVRA)2024-12-31$0-100.0%
Zymeworks Inc. (ZYME)2025-12-31$41.70M+38.7%

Compare CYRX, LFVN, ANAB, KROS side by side · Screen every company in Pharmaceutical Preparations ↗